Clinical Trials Directory

Trials / Completed

CompletedNCT04750434

PET MRI as a Staging Tool for Head and Neck Cancer

Status
Completed
Phase
Study type
Observational
Enrollment
20 (actual)
Sponsor
Hoag Memorial Hospital Presbyterian · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To explore the use of PET/MRI in the staging and pretreatment evaluation of patients with head and neck cancer and to compare this modality to standard PET/CT imaging.

Detailed description

This study is a prospective clinical study whereby an emerging technology, PET/MRI will be compared to a more standard imaging modality, PET/CT, using newly diagnosed head and neck cancer patients as subjects. PET/MRI will also be used in this study to explore the merits of this new technology in determining extent of disease, functional impact, and potential treatment outcome. In this study, subjects suitable for enrollment will be identified by the investigators involved in the study. These subjects will be identified through contact with these investigators and referred for enrollment per protocol. This protocol will include determining enrollment suitability based on inclusion and exclusion criteria. Once accepted as a candidate for the study, the newly diagnosed head and neck cancer patients will undergo both PET/CT and PET/MRI imaging within one week of each other. These studies will then be reviewed by a radiologist specializing in Head and Neck radiology familiar with PET imaging. The studies will be compared for any imaging differences. The imaging findings will then be correlated with pathological findings after surgery to determine if there are any consistent findings that correlate with adverse pathological findings, if found. The specific imaging data points to be determined by a radiologist will be tumor and metastatic disease size, SUV uptake, specific anatomic structures involved with tumor, imaging irregularities and characteristics of those imaging irregularities of the involved structures locally and regionally (if present), imaging characteristics of the different phases of MRI (T1, T2, etc.), and any other notable imaging characteristic.

Conditions

Timeline

Start date
2020-03-03
Primary completion
2024-08-16
Completion
2024-08-16
First posted
2021-02-11
Last updated
2024-10-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04750434. Inclusion in this directory is not an endorsement.